march
three
fatal
human
case
infect
influenza
viru
report
china
case
rapidli
recogn
china
although
case
report
summer
number
case
start
accumul
rapidli
fall
year
common
clinic
symptom
patient
infect
fever
cough
lymphocytopenia
diseas
progress
acut
respiratori
distress
syndrom
often
fatal
outcom
perimortem
lung
biopsi
show
diffus
alveolar
damag
infiltr
polymorphonuclear
cell
format
hyalin
membran
fibroprolif
chang
although
influenza
virus
subtyp
caus
human
infect
past
review
refer
notabl
outbreak
highli
pathogen
avian
influenza
viru
netherland
result
human
case
first
time
subtyp
viru
caus
mani
sever
case
viru
reassort
consist
eurasian
wild
bird
virus
virus
circul
poultri
china
amino
acid
substitut
ha
present
strain
increas
bind
ha
virus
sialic
acid
howev
singl
amino
acid
chang
seem
suffici
effici
humantohuman
transmiss
newli
emerg
viru
pose
signific
pandem
threat
due
rapid
accumul
case
sever
distinct
region
china
abil
virus
transmit
albeit
ineffici
via
respiratori
droplet
aerosol
ferret
model
order
allow
better
estim
effect
potenti
pandem
studi
strain
viru
cynomolgu
macaqu
model
model
chosen
close
reflect
human
physiolog
develop
pneumonia
cytokin
chemokin
respons
pattern
attach
viru
respiratori
tissu
macaqu
recent
shown
similar
human
frequent
use
anim
model
upon
inocul
influenza
viru
cynomolgu
macaqu
develop
transient
moder
diseas
viru
replic
upper
lower
respiratori
tract
emerg
influenza
viru
pathogen
season
influenza
viru
isol
pandem
viru
pathogen
spanish
influenza
viru
highli
pathogen
avian
influenza
hpai
viru
cynomolgu
macaqu
eight
cynomolgu
macaqu
male
femal
inocul
tissu
cultur
infecti
dose
via
combin
ocular
oral
intranas
intratrach
inocul
describ
previous
anim
start
show
sign
diseas
day
postinocul
dpi
clinic
diseas
peak
dpi
fig
moder
six
anim
show
obviou
respiratori
sign
increas
respir
rate
abdomin
breath
cough
see
tabl
supplement
materi
nasal
discharg
cough
note
one
anim
hematolog
blood
chemic
analys
reveal
abnorm
cours
infect
data
shown
dpi
ventraldors
later
chest
xray
taken
monitor
develop
pneumonia
radiograph
chang
lung
inocul
anim
observ
start
dpi
observ
inocul
anim
variou
degre
see
tabl
supplement
materi
interstiti
infiltr
observ
first
lower
right
lung
lobe
individu
anim
spread
time
right
middl
left
lower
left
middl
right
upper
lung
lobe
develop
sever
diffus
interstiti
infiltr
fig
also
see
tabl
supplement
materi
clinic
exam
perform
dpi
nasal
oropharyng
ocular
rectal
swab
collect
swab
initi
analyz
presenc
viral
rna
realtim
revers
transcriptionpcr
rtpcr
larg
number
swab
viral
rna
detect
nasal
oropharyng
ocular
swab
titrat
mdck
cell
rectal
swab
titrat
rectal
swab
posit
pcr
oropharyng
swab
posit
viru
titrat
dpi
remain
posit
anim
end
experi
dpi
fig
nasal
swab
posit
viru
titrat
viru
shed
via
nose
occur
anim
fig
despit
abil
influenza
virus
subtyp
caus
conjunct
ocular
swab
sporad
posit
viru
titrat
ocular
swab
collect
dpi
ocular
swab
collect
dpi
ocular
swab
collect
dpi
posit
viru
titer
data
shown
clinic
exam
bronchalveolar
lavag
bal
perform
sampl
analyz
presenc
infecti
viru
viru
could
isol
bal
fluid
anim
dpi
bal
fluid
remain
posit
throughout
experi
signific
amount
viru
still
detect
dpi
rang
fig
upon
necropsi
anim
dpi
gross
lesion
observ
lung
anim
variat
area
lung
affect
anim
least
two
lobe
show
gross
lesion
anim
vari
tissu
affect
fig
line
observ
xray
right
lung
lobe
sever
affect
left
lobe
like
result
intratrach
inocul
anatomi
lung
dpi
area
lung
display
gross
lesion
increas
three
right
lung
lobe
affect
anim
fig
anim
viru
titer
determin
tissu
sampl
collect
lung
lobe
lung
lesion
line
xray
gross
patholog
observ
dpi
viru
could
detect
three
lobe
right
lung
three
lung
lobe
left
lung
anim
fig
viru
present
collect
lung
lesion
unexpectedli
viru
titer
higher
lung
lesion
collect
lung
lobe
sampl
indic
widespread
viru
replic
throughout
lower
respiratori
tract
dpi
viru
titer
lung
lobe
lung
lesion
decreas
compar
dpi
although
decreas
statist
signific
number
anim
posit
viru
titrat
also
decreas
fig
tissu
respiratori
tract
ie
nasal
turbin
oropharynx
trachea
right
left
bronchu
viru
titer
gener
higher
lung
dpi
dpi
fig
interestingli
although
viru
titer
lung
lobe
lung
lesion
decreas
dpi
viru
titer
respiratori
tract
tissu
viru
could
also
detect
tonsil
mediastin
lymph
node
infect
anim
dpi
fig
viru
could
detect
conjunctiva
one
anim
dpi
remain
tissu
collect
dpi
ie
heart
liver
spleen
kidney
stomach
jejunum
ileum
transvers
colon
brain
analyz
presenc
viral
rna
realtim
rtpcr
except
liver
vrna
detect
anim
vrna
detect
sporad
tissu
except
heart
see
tabl
supplement
materi
sinc
cycl
threshold
valu
ct
almost
sampl
higher
level
viru
titrat
usual
success
ct
viru
titrat
attempt
sampl
dpi
histopatholog
lung
similar
anim
necropsi
character
mild
mark
acut
bronchointerstiti
pneumonia
pneumonia
character
microscop
mild
mark
thicken
alveolar
septa
fibrin
edema
neutrophil
macrophag
alveoli
contain
small
larg
amount
inflammatori
compon
fig
multifoc
hyalin
membran
observ
lumen
termin
bronchiol
frequent
contain
fibrin
edema
hyalin
membran
neutrophil
macrophag
multifoc
necrosi
loss
line
epithelium
inflamm
necrosi
bronchial
submucos
gland
frequent
note
mild
subacut
periglandular
inflamm
sever
chang
rang
neutrophil
macrophag
within
ductular
lumen
necrosi
acinar
ductular
epithelium
occasion
affect
entir
gland
larger
bronchiol
bronchi
gener
much
less
sever
affect
termin
airway
intact
viabl
line
epithelium
occasion
mild
neutrophil
lumin
exud
dpi
histopatholog
lung
character
mild
mark
subacut
chronic
bronchointerstiti
pneumonia
microscop
chang
character
presenc
neutrophil
macrophag
fibrin
edema
within
alveolar
septa
alveoli
termin
bronchiol
fig
addit
type
ii
pneumocyt
hyperplasia
observ
extens
portion
lung
lobe
larg
clump
alveolar
fibrin
frequent
engulf
neutrophil
macrophag
line
infiltr
fibroblast
immunohistochemistri
ihc
section
lung
demonstr
low
moder
number
antigenposit
alveolar
type
type
ii
pneumocyt
macrophag
epithelium
line
bronchiol
bronchi
bronchial
submucos
gland
fig
number
posit
stain
alveolar
pneumocyt
bronchial
bronchiolar
submucos
gland
epitheli
cell
similar
dpi
number
posit
stain
pulmonari
macrophag
increas
dpi
compar
dpi
posit
stain
alveolar
submucos
macrophag
cytoplasm
like
indic
activ
phagocytosi
viru
rather
replic
viru
cell
fig
antigenposit
macrophag
also
consist
note
within
mediastin
lymph
node
increas
number
cell
note
day
dpi
low
number
posit
stain
macrophag
note
pharyng
tonsil
oropharyng
trachea
extrapulmonari
bronchi
variat
individu
anim
histopatholog
lesion
remain
tissu
mild
subacut
conjunct
note
histolog
one
eight
anim
dpi
low
number
macrophag
posit
influenza
viru
antigen
present
submucosa
anim
viral
load
eye
swab
collect
anim
dpi
still
high
equivalentsml
like
indic
activ
viru
replic
influenza
virusposit
cell
note
epithelium
nasal
turbin
minim
inflamm
anim
dpi
fig
b
although
microscop
abnorm
tonsil
note
low
moder
number
posit
stain
tonsillar
macrophag
eight
anim
increas
amount
antigen
detect
dpi
focal
subacut
pharyng
ulcer
note
one
anim
dpi
rare
pharyng
epitheli
cell
posit
accord
ihc
site
ulcer
fig
one
anim
dpi
one
dpi
influenza
viru
antigen
could
detect
respiratori
epitheli
cell
nasopharynx
tissu
section
pharynx
macrophag
posit
ihc
tracheal
inflamm
affect
mucos
line
andor
submucos
gland
note
macaqu
ulcer
line
epithelium
occur
one
anim
dpi
one
dpi
epitheli
cell
macrophag
stain
posit
ihc
fig
f
minim
moder
subacut
inflamm
note
least
one
extrapulmonari
bronchi
anim
one
anim
extens
area
mark
inflamm
ulcer
upon
ihc
stain
section
bronchi
posit
stain
epitheli
cell
andor
macrophag
note
fig
h
serum
level
cytokin
chemokin
determin
sampl
obtain
dpi
transient
differ
observ
granulocyt
colonystimul
factor
gcsf
gamma
interferon
interleukin
receptor
antagonist
monocyt
chemoattract
protein
macrophag
inflammatori
protein
tumor
necrosi
factor
alpha
vascular
endotheli
growth
factor
vegf
level
dpi
statist
signific
increas
level
gcsf
fig
level
vegf
increas
time
point
increas
statist
signific
fig
also
data
shown
dpi
level
cytokin
chemokin
return
baselin
elucid
global
host
respons
specif
associ
site
virusinduc
airway
injuri
influenza
viru
macaqu
use
microarray
assess
transcript
profil
induc
lung
lesion
compar
adjac
lung
tissu
welch
test
p
chang
identifi
differenti
express
gene
deg
lesion
compar
lung
sampl
anim
dpi
fig
also
see
tabl
supplement
materi
gene
differenti
express
anim
upregul
downregul
lesion
compar
sampl
right
lower
lung
lobe
use
ingenu
pathway
analysi
ipa
assess
function
signific
molecular
signatur
construct
network
critic
molecul
base
direct
interact
ipa
knowledg
base
ipkb
fig
expect
numer
transcript
upregul
function
categori
previous
observ
cynomolgu
macaqu
model
influenza
infect
includ
known
mediat
antivir
immun
pattern
recognit
receptor
downstream
signal
molecul
interferon
interferonstimul
gene
interferonregulatori
factor
proinflammatori
cytokin
inflammatori
mediat
nlr
famili
also
identifi
number
upregul
gene
associ
leukocyt
migrat
differenti
sele
suggest
molecul
recruit
infiltr
effector
leukocyt
increas
site
lesion
line
observ
influx
neutrophil
macrophag
observ
microscop
lung
moreov
hyaluron
acid
synthas
molecul
known
associ
lung
injuri
strongli
upregul
lung
lesion
sampl
also
observ
sever
function
categori
molecul
downregul
lesion
rel
adjac
lung
tissu
fig
associ
predominantli
lipid
metabol
adipogenesi
regul
peroxisom
proliferatoractiv
receptor
alpha
also
observ
downregul
growth
factor
particularli
relat
insulin
signal
regul
glucos
level
insr
dpi
deg
identifi
lung
tissu
versu
lung
lesion
anim
euthan
dpi
see
fig
tabl
supplement
materi
due
substanti
variabl
anim
abl
determin
significantli
enrich
function
categori
time
point
next
upstream
analysi
function
ipa
use
identifi
drug
predict
act
signific
upstream
regul
key
deg
identifi
dpi
drug
predict
inhibit
patholog
host
respons
select
base
activ
z
score
neg
activ
z
score
predict
caus
opposit
inhibitori
effect
signific
gene
associ
patholog
lesion
find
confirm
use
connect
map
cmap
resourc
allow
comparison
transcript
signatur
multipl
cell
type
treat
librari
chemic
genet
perturbagen
determin
connect
score
also
neg
indic
compound
would
inhibitori
effect
transcript
signatur
associ
lesion
format
identifi
ten
compound
ipa
tabl
four
perturbagen
list
cmap
identifi
two
compound
met
criteria
ipa
cmap
rosiglitazon
simvastatin
predict
inhibitori
effect
patholog
host
respons
associ
lesion
influenza
viru
anim
tabl
molecul
involv
regul
lipid
biosynthesi
metabol
rosiglitazon
fdaapprov
diabet
drug
modul
ppar
activ
insulin
sensit
shown
affect
rna
viru
replic
virusinduc
inflamm
lung
inflamm
simvastatin
fdaapprov
statin
lower
blood
cholesterol
inhibit
coenzym
hmgcoa
reductas
shown
reduc
lung
inflamm
mous
model
airway
injuri
bacteri
infect
howev
simvastatin
shown
signific
effect
influenza
viru
pathogenesi
mice
besid
rosiglitazon
simvastatin
mainli
immunomodulatori
drug
predict
inhibitori
effect
patholog
host
respons
infect
abil
rosiglitazon
inhibit
replic
test
mdck
cell
treat
differ
concentr
drug
infect
multipl
infect
twentyfour
hour
addit
rosiglitazon
lower
concentr
statist
signific
p
twotail
unpair
test
reduct
viru
titer
supernat
treat
infect
cell
compar
mocktreat
cell
observ
see
fig
supplement
materi
small
cytotox
effect
drug
also
notic
time
point
mt
inner
salt
assay
see
fig
supplement
materi
h
treatment
inhibitori
effect
rosiglitazon
replic
could
longer
detect
data
shown
recent
emerg
influenza
viru
human
china
shift
focu
away
hpai
one
main
pandem
threat
although
much
attent
drawn
abil
viru
transmit
ferret
pathogen
influenza
viru
ferret
match
sever
diseas
observ
human
case
physiolog
cynomolgu
macaqu
lung
similar
human
cytokin
chemokin
respons
infect
macaqu
similar
human
moreov
shown
recent
pattern
attach
influenza
viru
respiratori
tissu
cynomolgu
macaqu
similar
attach
pattern
human
anim
model
frequent
use
influenza
viru
pathogenesi
studi
includ
ferret
therefor
studi
infect
cynomolgu
macaqu
detail
agreement
observ
abund
attach
influenza
viru
human
upper
lower
respiratori
tract
replic
viru
ex
vivo
cultur
human
upper
well
lower
respiratori
tract
viru
replic
well
upper
lower
respiratori
tract
cynomolgu
macaqu
indic
viru
titer
nasal
turbin
oronasopharyng
trachea
bronchi
lung
tissu
sampl
reflect
previous
describ
receptor
distribut
influenza
viru
macaqu
respiratori
tract
surprisingli
viru
titer
nasal
turbin
oronasopharyng
trachea
bronchi
decreas
dpi
unlik
viru
titer
lung
sampl
decreas
extend
viru
replic
upper
respiratori
tract
could
result
prolong
viru
shed
thu
increas
risk
viru
transmiss
histopatholog
lung
fatal
human
case
similar
albeit
sever
observ
cynomolgu
macaqu
diffus
alveolar
damag
infiltr
polymorphonuclear
cell
format
hyalin
membran
later
onset
symptom
pneumocyt
hyperplasia
fibroprolif
chang
howev
clinic
histopatholog
infect
sever
cynomolgu
macaqu
describ
human
high
case
fatal
rate
although
viral
characterist
could
caus
differ
diseas
sever
human
macaqu
anoth
possibl
explan
discrep
diseas
sever
could
high
percentag
human
case
underli
medic
complic
sinc
influenza
viru
strain
isol
human
case
substitut
na
render
partial
resist
treatment
neuraminidas
inhibitor
import
identifi
drug
either
directli
inhibit
viru
replic
host
reduc
sever
diseas
level
lung
injuri
infect
analyz
gene
express
profil
lung
lesion
compar
adjac
infect
nonlesion
lung
tissu
abl
predict
drug
report
act
upstream
regul
gene
may
thu
play
role
develop
lung
lesion
infect
one
predict
drug
rosiglitazon
modestli
reduc
replic
influenza
viru
vitro
similar
data
analysi
result
identif
compound
reduc
replic
middl
east
respiratori
syndrom
coronaviru
vitro
howev
valid
approach
yet
test
vivo
thu
analysi
gene
express
profil
hint
new
avenu
treatment
explor
vivo
model
rather
reveal
novel
treatment
directli
applic
clinic
although
difficult
compar
studi
investig
pathogen
differ
influenza
virus
macaqu
model
differ
inocul
rout
dose
use
sampl
scheme
overlap
studi
infect
macaqu
studi
similar
describ
previous
studi
anim
develop
transient
clinic
sign
viru
replic
upper
well
lower
respiratori
tract
similar
histopatholog
lesion
lower
respiratori
tract
importantli
infect
seem
clinic
sever
infect
isol
pandem
viru
shed
throat
higher
anim
larger
area
lung
affect
gross
lesion
inocul
cynomolgu
macaqu
season
influenza
viru
result
infect
mild
even
asymptomat
diseas
cynomolgu
macaqu
inocul
via
rout
dose
spanish
influenza
viru
develop
lethal
diseas
hpai
influenza
viru
inocul
macaqu
dose
caus
sever
diseas
influenza
viru
studi
thu
emerg
influenza
viru
pathogen
season
influenza
viru
isol
pandem
viru
pathogen
spanish
influenza
viru
hpai
viru
cynomolgu
macaqu
howev
pathogen
viru
may
decreas
viru
adapt
sole
use
sialic
acid
receptor
entri
pandem
influenza
virus
date
done
exclus
attach
sialic
acid
would
like
result
shift
replic
mainli
upper
respiratori
tract
human
like
result
less
sever
diseas
describ
pandem
viru
upon
adapt
hpai
viru
effici
transmiss
via
respiratori
droplet
aerosol
anim
experi
approv
institut
anim
care
use
committe
rocki
mountain
laboratori
perform
follow
guidelin
associ
assess
accredit
laboratori
anim
care
intern
aaalac
certifi
staff
aaalacapprov
facil
madindarbi
canin
kidney
mdck
cell
cultur
eagl
modifi
essenti
medium
emem
gibco
supplement
fetal
calf
serum
fc
iuml
penicillin
streptomycin
mm
glutamin
mgml
sodium
bicarbon
nonessenti
amino
acid
passag
obtain
center
diseas
control
atlanta
ga
passag
mdck
cell
eight
cynomolgu
macaqu
male
femal
age
year
kg
inocul
via
combin
intratrach
ml
intranas
oral
ml
ocular
rout
anim
observ
twice
daili
clinic
sign
diseas
score
use
previous
describ
clinic
score
system
day
postinocul
clinic
exam
perform
anesthet
anim
later
x
ray
taken
analyz
veterinarian
nasal
oral
urogenit
rectal
swab
collect
ml
dulbecco
modifi
essenti
medium
dmem
uml
penicillin
streptomycin
bronchoalveolar
lavag
bal
perform
use
ml
steril
salin
solut
blood
collect
hematolog
blood
chemistri
analysi
peripher
blood
mononuclear
cell
pbmc
isol
total
white
blood
cell
count
lymphocyt
platelet
reticulocyt
red
blood
cell
count
hemoglobin
hematocrit
valu
mean
cell
volum
mean
corpuscular
volum
mean
corpuscular
hemoglobin
concentr
determin
edtacontain
blood
hemavet
hemoglobin
analyz
drew
scientif
pbmc
isol
centrifug
histopaqu
gradient
sigma
per
manufactur
recommend
dpi
macaqu
euthan
sampl
conjunctiva
right
left
eye
nasal
turbin
tonsil
oronasopharyng
trachea
right
left
bronchi
six
lung
lobe
lung
lesion
mediastin
lymph
node
heart
liver
spleen
kidney
stomach
jejuna
ilea
transvers
colon
olfactori
bulb
cerebella
brain
stem
bone
marrow
collect
percentag
lung
surfac
area
affect
gross
lung
lesion
quantit
lung
lobe
ventral
dorsal
boardcertifi
veterinari
pathologist
time
necropsi
histopatholog
immunohistochemistri
perform
macaqu
tissu
fixat
day
neutral
buffer
formalin
embed
paraffin
tissu
section
stain
hematoxylin
eosin
h
e
detect
influenza
viru
antigen
immunohistochemistri
perform
use
antinp
monoclon
antibodi
evl
netherland
primari
antibodi
rna
extract
swab
bal
fluid
wholeblood
sampl
use
qiaamp
viral
rna
kit
qiagen
accord
manufactur
instruct
tissu
store
process
tissu
sampl
mg
homogen
rlt
buffer
rna
extract
use
rneasi
kit
qiagen
onestep
realtim
rtpcr
target
matrix
gene
influenza
viru
perform
use
quantifast
probe
kit
qiagen
accord
instruct
manufactur
use
primer
probe
describ
refer
virus
titrat
endpoint
dilut
mdck
cell
mdck
cell
inocul
tenfold
serial
dilut
cultur
supernat
one
hour
inocul
cell
wash
phosphatebuff
salin
pb
supplement
infect
medium
emem
supplement
iuml
penicillin
streptomycin
mm
glutamin
mgml
sodium
bicarbon
nonessenti
amino
acid
trypsin
three
day
inocul
supernat
infect
cell
cultur
test
agglutin
activ
use
turkey
red
blood
cell
indic
infect
cell
infecti
titer
calcul
replic
spearmankarb
method
serum
sampl
analysi
cytokinechemokin
level
inactiv
gamma
radiat
megarad
accord
standard
oper
procedur
concentr
granulocyt
colonystimul
factor
granulocytemacrophag
colonystimul
factor
receptor
antagonist
solubl
ligand
transform
growth
factor
vascular
endotheli
growth
factor
vegf
measur
bioplex
instrument
biorad
use
nonhuman
primat
cytokin
milliplex
map
kit
millipor
accord
manufactur
instruct
rna
extract
use
qiagen
microrneasi
spin
column
per
manufactur
protocol
lowyield
sampl
concentr
use
rna
clean
concentr
kit
zymo
research
irvin
ca
multipl
lesion
collect
anim
equal
mass
rna
sampl
sampl
per
anim
pool
investig
comprehens
signatur
multipl
patholog
site
within
individu
probe
label
carri
use
agil
lowinput
process
protocol
hybrid
agil
rhesu
macaqu
microarray
agil
technolog
santa
clara
ca
use
manufactur
onecolor
analysi
protocol
comparison
differenti
express
gene
deg
infect
lung
lung
lesion
raw
array
data
upload
genedata
analyst
genedata
inc
san
francisco
ca
data
normal
use
quantil
normal
method
ratio
express
calcul
rel
mean
probe
valu
right
lower
lung
lobe
sampl
per
time
point
lesion
versu
lung
comparison
statist
signific
deg
identifi
use
welch
test
p
fold
chang
hierarch
cluster
deg
perform
unweight
averag
method
unweight
pair
group
arithmet
mean
upgma
use
spotfir
decisionsit
tibco
somervil
analysi
function
enrich
perform
use
ingenu
pathway
analysi
ipa
softwar
ingenu
system
redwood
citi
ca
upstream
drug
efficaci
predict
made
use
upstream
analysi
function
ipa
connect
map
broad
institut
cambridg
drug
predict
inhibit
patholog
host
respons
select
base
activ
z
score
neg
activ
z
score
predict
caus
opposit
inhibitori
effect
signific
gene
associ
patholog
lesion
studi
sought
compound
activ
z
score
less
p
valu
less
find
confirm
use
connect
map
cmap
cmap
assign
enrich
score
rang
accept
compound
cmap
enrich
score
less
compound
induc
transcript
profil
neg
connect
gene
express
signatur
associ
lung
patholog
confirm
drug
may
induc
transcript
profil
inhibitori
tissu
damag
lesion
format
confluent
mdck
cell
cultur
plate
infect
triplic
influenza
viru
multipl
infect
h
cell
wash
pb
infect
medium
contain
rosiglitazon
ad
cell
cell
incub
h
supernat
harvest
store
subsequ
viru
titrat
replac
fresh
infect
medium
contain
rosiglitazon
supernat
collect
h
infect
store
subsequ
viru
titrat
determin
potenti
cytotox
effect
rosiglitazon
mdck
cell
simultan
plate
cultur
plate
treat
rosiglitazon
h
incub
cytotox
test
use
celltit
aqueou
onesolut
cell
prolifer
assay
mt
promega
accord
manufactur
instruct
raw
microarray
data
deposit
ncbi
gene
express
omnibu
databas
also
avail
public
http
viromicswashingtonedu
